Arthritis Clinical Trials in Las Vegas
View 13 new treatments for Arthritis in Las Vegas, NV, and nearby areas, such as Henderson. Every day, Power helps hundreds of arthritis patients connect with leading medical research.Guselkumab for Psoriatic Arthritis
Janssen Clinic, Las Vegas + 1 more
This trial is testing guselkumab, a medication that reduces inflammation, in patients with psoriatic arthritis affecting the spine. It works by blocking a protein called IL-23 to help reduce symptoms and inflammation. Guselkumab is the first IL-23 specific inhibitor approved for the treatment of moderate-to-severe psoriasis.Show More
TG-C for Knee Osteoarthritis
Kolon TissueGene Clinic, Las Vegas + 2 more
This trial tests TG-C, an injection into the knee, for people with moderate to severe knee osteoarthritis. It aims to see if TG-C can reduce pain and improve knee function by potentially altering the disease. The study will monitor patients for safety and effectiveness over time. TG-C has been previously studied for its potential to improve knee joint function and reduce pain in osteoarthritis patients.Show More
RTX-GRT7039 Injections for Knee Osteoarthritis
Grünenthal Clinic, North las vegas + 3 more
This trial uses knee injections called RTX-GRT7039 for patients with knee osteoarthritis who still have pain despite usual treatments. The injections aim to reduce knee pain, possibly by affecting pain pathways or inflammation.Show More
No Placebo Trial
Retatrutide for Obesity
Eli Lilly Clinic, Las Vegas + 1 more
The purpose of this study is to evaluate the efficacy and safety of retatrutide in participants who have obesity or overweight (J1I-MC-GZBJ master protocol) including subsets of participants who have knee osteoarthritis (OA) (J1I-MC-GOA1) or who have obstructive sleep apnea (OSA) (J1I-MC-GSA1). This study will last about 89 weeks and will include up to 24 visits.Show More
TG-C for Osteoarthritis of the Knee
Kolon TissueGene Clinic, Las Vegas + 1 more
This trial tests TG-C, an injection into the knee, for patients with moderate to severe osteoarthritis. It aims to reduce pain and improve knee function by potentially modifying the disease. TG-C has shown promise in previous studies for managing knee osteoarthritis.Show More
A Study Utilizing Patient-Reported Outcomes to Evaluate the Safety and Efficacy of Lorecivivint (SM04690) for the Treatment of Moderately to Severely Symptomatic Knee Osteoarthritis (STRIDES)
Biosplice Clinic, Las Vegas + 1 more
This trial tests a knee injection called lorecivivint for people with severe knee osteoarthritis. The injection aims to reduce pain and improve movement by targeting the painful knee directly. Lorecivivint (LOR) is being tested for its potential to treat osteoarthritis.Show More
Pentosan Polysulfate Sodium Injections for Osteoarthritis
Paradigm Biopharmaceuticals Clinic, Las Vegas + 2 more
This trial tests if a new treatment can reduce pain and improve function in people with knee osteoarthritis. The medication aims to reduce inflammation and help repair knee joint damage.Show More
GSK3858279 for Osteoarthritis Pain
GlaxoSmithKline Clinic, Henderson + 1 more
This trial is testing a new medication called GSK3858279 to find the best dose for reducing knee pain in people with moderate to severe osteoarthritis. The goal is to determine how much of the medication is needed to be effective and safe. This will help in managing knee pain better for those who suffer from this condition.Show More
OA-SYS for Osteoarthritis
Ageless Clinic, Las Vegas + 1 more
This study is being conducted to evaluate the safety and tolerability of OA-SYS in patients with moderate to severe OA of the knee joint.
No Placebo Trial
LLLT for Hand Osteoarthritis
Research Clinic, Nellis Air Force Base + 1 more
This trial is testing a special light therapy called Low-Level Laser Therapy (LLLT) to see if it helps reduce pain and improve function in adults with hand osteoarthritis. The laser works by warming up tissues to relieve pain and improve blood flow. Low-Level Laser Therapy (LLLT) has been used in various fields to promote tissue repair, reduce inflammation, and relieve pain.Show More
Frequently Asked Questions
How much do arthritis clinical trials pay?
Each trial will compensate patients a different amount, but $50-100 for each visit is a fairly common range. Further, most trials will cover the costs of an Uber to-and-from the clinic. Factors that can affect compensation include the phase of the trial, the length of the trial, the frequency of visits, and the specific condition being studied.
Do I need to be insured to participate in a medical study?
Clinical trials are almost always free to participants, and so do not require insurance. The only exception here are trials focused on Cancer, because only a small part of the typical treatment plan is actually experimental. For these cancer trials, participants typically need insurance to cover all the non-experimental components.
How do arthritis clinical trials work?
After a researcher reviews your profile, they may choose to invite you in to a screening appointment, where they'll determine if you meet 100% of the eligibility requirements. If you do, you'll typical be sorted into one of the treatment groups, and will receive your study drug. For some trials, there is a chance you'll receive a placebo. Across arthritis trials in Las Vegas, 42% of clinical trials have a placebo. Typically you'll be required to check-in with the clinic every month or two. The average trial length in this city for arthritis patients is 6 Months.
What does the "phase" of a clinical trial mean?
The phase of a trial reveals what stage the drug is in getting approval for a specific condition. Phase 3 trials are in the final step before approval. The drug already has data showing both safety and effectiveness. Phase 2 trials are those where the drug has some data showing safety in humans, but where effectiveness has typically only been shown in animals and non-human experiments. Phase 1 trials are the trials where we don't have safety data in humans. As a general rule, phase 3 trials are more promising than phase 2, and phase 2 trials are more promising than phase 1.
Where in Las Vegas is research being conducted for arthritis?
Excel Clinical Research in Las Vegas is conducting clinical trials for arthritis, with approximately 3 trials ongoing. These trials are taking place in the central area of the city.
What promising new drugs are being tested?
In Las Vegas, arthritis research is exploring treatments like Monoclonal Antibodies and Neuromodulation Devices. Specific interventions being studied include Guselkumab, Hyalofast, and Lorecivivint.